Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital

被引:32
|
作者
Aquino-Andrade, Alejandra [1 ]
Merida-Vieyra, Jocelin [1 ]
Arias de la Garza, Eduardo [2 ]
Arzate-Barbosa, Patricia [3 ]
De Colsa Ranero, Agustin [1 ,2 ]
机构
[1] Inst Nacl Pediat, Mol Microbiol Lab, Insurgentes Sur 3700-C, Mexico City 04530, DF, Mexico
[2] Inst Nacl Pediat, Pediat Infect Dis Dept, Mexico City, DF, Mexico
[3] Inst Nacl Pediat, Clin Bacteriol Lab, Mexico City, DF, Mexico
来源
BMC MICROBIOLOGY | 2018年 / 18卷
关键词
Carbapenemase-producing Enterobacteriaceae; Pediatrics; Mexico; NDM-1; KPC-2; OXA-48; OXA-232; METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; RESISTANT ENTEROBACTERIACEAE; GLOBAL DISSEMINATION; TREATMENT OPTIONS; INFECTIONS; SPREAD; NDM-1; EMERGENCE;
D O I
10.1186/s12866-018-1166-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Carbapenemases-producing Enterobacteriaceae (CPE) are a worldwide public health emergency. In Mexico, reports of CPE are limited, particularly in the pediatric population. Here, we describe the clinical, epidemiological, and molecular characteristics of seven consecutive cases in a third-level pediatric hospital in Mexico City over a four-month period during 2016. Results: The Enterobacteriaceae identified were three Escherichia coli strains (producing OXA-232, NDM-1 and KPC-2), two Klebsiella pneumoniae strains (producing KPC-2 and NDM-1), one Klebsiella oxytoca strain producing OXA-48 and one Enterobacter cloacae strain producing NDM-1. The majority of patients had underlying disesases, three were immunocompromised, and three had infections involved the skin and soft tissues. Half patients died as a result of CPE infection. Conclusions: This study represents the first report of E coil ST131-O25b clone producing NDM-1 in Latin America. In addition, this study is the first finding of K oxytoca producing OXA-48 and E. coli producing OXA-232 in Mexican pediatric patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Carbapenemase-producing Enterobacteriaceae digestive carriage at hospital readmission and the role of antibiotic exposure
    Evain, S.
    Bourigault, C.
    Juvin, M-E
    Corvec, S.
    Lepelletier, D.
    JOURNAL OF HOSPITAL INFECTION, 2019, 102 (01) : 25 - 30
  • [22] Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital - a five-year retrospective study
    Gorgulho, Ana
    Grilo, Ana Maria
    de Figueiredo, Manuel
    Selada, Joana
    GERMS, 2020, 10 (02): : 95 - 103
  • [23] Carbapenemase-producing Enterobacteriaceae: use of a dynamic registry of cases and contacts for outbreak management
    Clarivet, B.
    Pantel, A.
    Morvan, M.
    Pierre, H. Jean
    Parer, S.
    Jumas-Bilak, E.
    Lotthe, A.
    JOURNAL OF HOSPITAL INFECTION, 2016, 92 (01) : 73 - 77
  • [24] Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan
    Koyano, Saho
    Saito, Ryoichi
    Nagai, Ran
    Tatsuno, Keita
    Okugawa, Shu
    Okamura, Noboru
    Moriya, Kyoji
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 446 - 450
  • [25] Genotypes and prevalence of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa in a hospital in Saudi Arabia
    Al-Tawfiq, Jaffar A.
    Rabaan, Ali A.
    Saunar, Justin, V
    Bazzi, Ali M.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (01) : 50 - 53
  • [26] Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
    Tamma, Pranita D.
    Goodman, Katherine E.
    Harris, Anthony D.
    Tekle, Tsigereda
    Roberts, Ava
    Taiwo, Abimbola
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 257 - 264
  • [27] Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
    Tamma, Pranita D.
    Huang, Yanjie
    Opene, Belita N. A.
    Simner, Patricia J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6425 - 6429
  • [28] Validation of the Giannella Risk Score for the Prediction of Infection by Carbapenemase-producing Enterobacteriaceae in the Pediatric Population
    Garazzino, Silvia
    Balletto, Elisa
    Licciardi, Francesco
    Denina, Marco
    Carraro, Francesca
    Contino, Amalia
    Palmero, Candida
    Ugolotti, Elisabetta
    Silvestro, Erika
    Castagnola, Elio
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (02) : 112 - 116
  • [29] Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan
    Lai, Chung-Chih
    Wu, Un-In
    Wang, Jann-Tay
    Chang, Shan-Chwen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (08) : 492 - 496
  • [30] Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients
    Lapointe-Shaw, L.
    Voruganti, T.
    Kohler, P.
    Thein, H. -H.
    Sander, B.
    McGeer, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (06) : 1047 - 1055